image
image
user-login
Patent search/

COMBINATION CANCER TREATMENT USING A PD-1 ANTAGONIST, AN ILT4 ANTAGONIST, AND LENVATINIB OR SALTS THEREOF.

Patent Search in India

  • tick

    Extensive patent search conducted by a registered patent agent

  • tick

    Patent search done by experts in under 48hrs

₹999

₹399

Talk to expert

COMBINATION CANCER TREATMENT USING A PD-1 ANTAGONIST, AN ILT4 ANTAGONIST, AND LENVATINIB OR SALTS THEREOF.

PCT NATIONAL PHASE APPLICATION

Published

date

Filed on 1 August 2022

Patent Information

Application ID202217044031
Date of Application01/08/2022

Documents

NameDate
202217044031-FORM 18 [02-01-2024(online)].pdf02/01/2024
202217044031-Correspondence-140723.pdf28/08/2023
202217044031-Others-140723.pdf28/08/2023
202217044031-FORM 3 [15-11-2022(online)].pdf15/11/2022
202217044031-Correspondence-300922-1.pdf25/10/2022
202217044031-Correspondence-300922.pdf25/10/2022
202217044031-GPA-300922-1.pdf25/10/2022
202217044031-GPA-300922.pdf25/10/2022
202217044031-FORM-26 [14-09-2022(online)].pdf14/09/2022
202217044031-FORM-26 [31-08-2022(online)].pdf31/08/2022
202217044031-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [01-08-2022(online)].pdf01/08/2022
202217044031-COMPLETE SPECIFICATION [01-08-2022(online)].pdf01/08/2022
202217044031-DECLARATION OF INVENTORSHIP (FORM 5) [01-08-2022(online)].pdf01/08/2022
202217044031-DRAWINGS [01-08-2022(online)].pdf01/08/2022
202217044031-FORM 1 [01-08-2022(online)].pdf01/08/2022
202217044031-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [01-08-2022(online)].pdf01/08/2022
202217044031-PRIORITY DOCUMENTS [01-08-2022(online)].pdf01/08/2022
202217044031-PROOF OF RIGHT [01-08-2022(online)].pdf01/08/2022
202217044031-Sequence Listing in PDF [01-08-2022(online)].pdf01/08/2022
202217044031-Sequence Listing in txt [01-08-2022(online)].txt01/08/2022
202217044031-STATEMENT OF UNDERTAKING (FORM 3) [01-08-2022(online)].pdf01/08/2022
earn

Refer a friend